Literature DB >> 21824919

Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden.

Bengt Zöller1, Xinjun Li, Jan Sundquist, Kristina Sundquist.   

Abstract

BACKGROUND: This nationwide study sought to determine age- and gender-specific familial risks in siblings hospitalized for venous thromboembolism (VTE). METHODS AND
RESULTS: The Swedish Multigeneration Register on 0- to 75-year-old subjects was linked to the Hospital Discharge Register for the years 1987-2007. Standardized incidence ratios were calculated for individuals whose siblings were hospitalized for VTE compared with those whose siblings were not affected. Among a total of 45 362 hospitalized cases with VTE, 2393 affected siblings were identified, with a familial standardized incidence ratio of 2.45 (95% confidence interval [CI], 1.66 to 3.61). Gender-specific differences in incidence rates were observed. The familial risks were significantly increased from the age of 10 to 69 years, with a familial standardized incidence ratio of 4.77 (95% CI, 1.96 to 10.83) at ages 10 to 19 years, which decreased to 2.08 (95% CI, 1.35 to 3.20) at ages 60 to 69 years, although the absolute risk increased with age. The familial standardized incidence ratios for siblings with 2 and ≥3 affected probands were 51.87 (95% CI, 31.47 to 85.00) and 53.69 (95% CI, 25.59 to 108.50), respectively. Spouses had low familial risks (standardized incidence ratio=1.07; 95% CI, 1.04 to 1.10; observed spouse cases=3900).
CONCLUSIONS: Familial factors, although influenced by age and gender, are important risk factors for VTE. The present study shows that VTE is aggregated in families and suggests that uncovering the sources of familial aggregation (genetic and nongenetic) may be worthwhile. Moreover, in a small fraction of siblings, the familial risk was very high, suggesting segregation of rare but strong genetic risk factors.

Entities:  

Mesh:

Year:  2011        PMID: 21824919     DOI: 10.1161/CIRCULATIONAHA.110.965020

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  Neighborhood deprivation and hospitalization for venous thromboembolism in Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

2.  A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.

Authors:  Weihong Tang; Martina Teichert; Daniel I Chasman; John A Heit; Pierre-Emmanuel Morange; Guo Li; Bruno H Ch Stricker; Paul M Ridker; Aaron R Folsom; Nicholas L Smith; Nathan Pankratz; Frank W Leebeek; Guillaume Paré; Mariza de Andrade; Christophe Tzourio; Bruce M Psaty; Saonli Basu; Rikje Ruiter; Lynda Rose; Sebastian M Armasu; Thomas Lumley; Susan R Heckbert; André G Uitterlinden; Mark Lathrop; Kenneth M Rice; Mary Cushman; Albert Hofman; Jean-Charles Lambert; Nicole L Glazer; James S Pankow; Jacqueline C Witteman; Philippe Amouyel; Joshua C Bis; Edwin G Bovill; Xiaoxiao Kong; Russell P Tracy; Eric Boerwinkle; Jerome I Rotter; David-Alexandre Trégouët; Daan W Loth
Journal:  Genet Epidemiol       Date:  2013-05-05       Impact factor: 2.135

3.  Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.

Authors:  N S Roetker; S M Armasu; J S Pankow; P L Lutsey; W Tang; M A Rosenberg; T M Palmer; R F MacLehose; S R Heckbert; M Cushman; M de Andrade; A R Folsom
Journal:  J Thromb Haemost       Date:  2017-06-06       Impact factor: 5.824

4.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

5.  Factors that predict thrombosis in relatives of patients with venous thromboembolism.

Authors:  Francis Couturaud; Christophe Leroyer; Cecile Tromeur; Jim A Julian; Susan R Kahn; Jeffrey S Ginsberg; Philip S Wells; James D Douketis; Dominique Mottier; Clive Kearon
Journal:  Blood       Date:  2014-07-21       Impact factor: 22.113

6.  Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.

Authors:  Abrar Ahmad; Ashfaque A Memon; Jan Sundquist; Peter J Svensson; Bengt Zöller; Kristina Sundquist
Journal:  Gene       Date:  2018-01-09       Impact factor: 3.688

7.  Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.

Authors:  Marta Crous-Bou; Immaculata De Vivo; Carlos A Camargo; Raphaëlle Varraso; Francine Grodstein; Majken K Jensen; Peter Kraft; Samuel Z Goldhaber; Sara Lindström; Christopher Kabrhel
Journal:  Thromb Haemost       Date:  2016-06-16       Impact factor: 5.249

8.  Thromboembolic complications following a first isolated episode of superficial vein thrombosis: a cross-sectional retrospective study.

Authors:  Lauren N Bell; Richard L Berg; John R Schmelzer; Hong Liang; Joseph J Mazza; Rajan Kanth; Christopher L Bray; Calixto B Zaldivar; Steven H Yale
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

9.  Epidemiology of venous thromboembolism in the Framingham Heart Study.

Authors:  Marja K Puurunen; Philimon N Gona; Martin G Larson; Joanne M Murabito; Jared W Magnani; Christopher J O'Donnell
Journal:  Thromb Res       Date:  2016-06-29       Impact factor: 3.944

10.  Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans.

Authors:  A R Folsom; W Tang; L-C Weng; N S Roetker; M Cushman; S Basu; J S Pankow
Journal:  J Thromb Haemost       Date:  2015-12-29       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.